SALD-7500nano Expands Measurement of Nanoparticles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SALD-7500nano Expands Measurement of Nanoparticles


Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

Shimadzu introduces the SALD-7500nano, a particle size analyzer that can measure nanoparticles in low concentrations or those that demonstrate high light absorption. The system is capable of a wide measurement range, from primary particles to sub-visible particles and contaminants, and allows measurements across a concentration range from 0.01 ppm to 20%. It enables measurement of micro bubbles from 100 nm to 60 μm and real-time tracking of changes in bubble diameter. The SALD-7500nano features a single light source and wide-angle detection method, allowing high-speed measurement to a minimum of one second and real-time display of particle size distribution at one-second intervals. The system uses an omnidirectional shock absorption frame to improve instrument stability and provide high reproducibility, while built-in self-diagnostic functions ensure easy maintenance.

Shimadzu Scientific Instruments

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here